STS_3 Ladies 1440 x 900 px.png

Seize the sound

Be the hearing specialist who helps your clients seize the sound.

Find out more

According to the World Health Organization, there are about 466 million people with disabling hearing loss around the world.1

In children, hearing loss can be associated with delayed speech and language skills, and may have an impact on their learning at school and development of social skills.2 For adults, there are reported associations between hearing loss and loneliness, and research has suggested that hearing loss could be linked to depression and dementia in older adults.3,4,5

However, there are options beyond hearing aids to help your patients improve their hearing and enhance their quality of life.

Since launching the world's first cochlear implant system over 40 years ago, Cochlear has provided more than 700,000 implantable devices, helping people of all ages to hear.

Cochlear's promise "Hear now. And always" reflects our philosophy of a lifetime commitment to people who choose our products.


Disclaimer

This material is intended for health professionals. If you are a consumer, please seek advice from your health professional about treatments for hearing loss. Outcomes may vary, and your health professional will advise you about the factors which could affect your outcome. Always read the instructions for use. Not all products are available in all countries. Please contact your local Cochlear representative for product information.

For a full list of Cochlear’s trademarks, please visit our Terms of Use page.

In Australia, Cochlear™ Nucleus® implant systems are intended for the treatment of moderately severe to profound hearing loss.

In Australia, Baha® bone conduction implant systems are intended for the treatment of moderate to profound hearing loss.

In Australia, the Cochlear™ Osia® System is indicated for patients with conductive, mixed hearing loss and single-sided sensorineural deafness (SSD) aged 10 years and above with up to 55 decibels sensorineural hearing loss. Patients should have sufficient bone quality and quantity to support successful implant placement. Surgery is required to use this product. Any surgical procedure carries risk.

For Cochlear™ Nucleus®, Osia® and Baha® systems: This product is not available for purchase by the general public. For information on funding and reimbursement please contact your health care professional.

Any testimonial featured on this website is intended for an Australian audience only.

References

  1. Deafness and hearing loss [Internet]. World Health Organization. 2018 [cited 26 September 2018]. Available from: http://www.who.int/news-room/fact-sheets/detail/deafness-and-hearing-loss
  2. Effects of Hearing Loss on Development [Internet]. Asha.org. 2018 [cited 26 September 2018]. Available from: https://www.asha.org/public/hearing/effects-of-hearing-loss-on-development/
  3. Contrera K, Sung Y, Betz J, Li L, Lin F. Change in loneliness after intervention with cochlear implants or hearing aids. The Laryngoscope. 2017;127(8):1885-1889.
  4. Rutherford B, Brewster K, Golub J, Kim A, Roose S. Sensation and Psychiatry: Linking Age-Related Hearing Loss to Late-Life Depression and Cognitive Decline. American Journal of Psychiatry. 2018;175(3):215-224.
  5. World Health Organization. World Report on Hearing. Geneva: World Health Organization; 2021. Available from: https://www.who.int/publications/i/item/world-report-on-hearing Accessed 4 March 2022.